RhumbLine Advisers’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,975
| Closed | -$28.2K | – | 4185 |
|
|
2025
Q1 | $28.2K | Sell |
6,975
-370
| -5% | -$1.5K | ﹤0.01% | 3683 |
|
|
2024
Q4 | $77.8K | Sell |
7,345
-217
| -3% | -$2.3K | ﹤0.01% | 3547 |
|
|
2024
Q3 | $187K | Sell |
7,562
-328
| -4% | -$8.1K | ﹤0.01% | 3271 |
|
|
2024
Q2 | $222K | Buy |
7,890
+543
| +7% | +$15.3K | ﹤0.01% | 3167 |
|
|
2024
Q1 | $299K | Buy |
7,347
+160
| +2% | +$6.51K | ﹤0.01% | 2980 |
|
|
2023
Q4 | $119K | Buy |
7,187
+49
| +0.7% | +$808 | ﹤0.01% | 3396 |
|
|
2023
Q3 | $271K | Sell |
7,138
-5
| -0.1% | -$189 | ﹤0.01% | 2982 |
|
|
2023
Q2 | $393K | Sell |
7,143
-348
| -5% | -$19.1K | ﹤0.01% | 2844 |
|
|
2023
Q1 | $322K | Buy |
7,491
+58
| +0.8% | +$2.49K | ﹤0.01% | 2591 |
|
|
2022
Q4 | $292K | Buy |
7,433
+367
| +5% | +$14.4K | ﹤0.01% | 2686 |
|
|
2022
Q3 | $375K | Buy |
7,066
+588
| +9% | +$31.2K | ﹤0.01% | 2627 |
|
|
2022
Q2 | $425K | Buy |
6,478
+2,062
| +47% | +$135K | ﹤0.01% | 2580 |
|
|
2022
Q1 | $324K | Buy |
4,416
+28
| +0.6% | +$2.05K | ﹤0.01% | 2617 |
|
|
2021
Q4 | $311K | Sell |
4,388
-123
| -3% | -$8.72K | ﹤0.01% | 2689 |
|
|
2021
Q3 | $1.13M | Buy |
4,511
+197
| +5% | +$49.4K | ﹤0.01% | 2166 |
|
|
2021
Q2 | $1.16M | Buy |
4,314
+94
| +2% | +$25.3K | ﹤0.01% | 2178 |
|
|
2021
Q1 | $1.2M | Buy |
4,220
+2,850
| +208% | +$811K | ﹤0.01% | 2124 |
|
|
2020
Q4 | $388K | Buy |
1,370
+247
| +22% | +$70K | ﹤0.01% | 2549 |
|
|
2020
Q3 | $347K | Buy |
+1,123
| New | +$347K | ﹤0.01% | 2453 |
|